Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity
Acute myeloid leukemia (AML) is an aggressive blood cancer where immature stem cells in the bone marrow multiply rapidly, disrupting blood cell production and leading to infections, anemia, and bleeding [...]
Saved in:
| Main Author: | Deepesh Kumar Verma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-03-01
|
| Series: | Proceedings |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2504-3900/100/1/12 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognosis of RUNX1-RUNX1T1 Rearrangement in Newly Diagnosed Acute Myeloid Leukemia Patients
by: Halima Babar, et al.
Published: (2023-10-01) -
Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment
by: LL Girshova, et al.
Published: (2016-10-01) -
Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1‐RUNX1T1
by: Yibo Wu, et al.
Published: (2025-01-01) -
Association of a mutation in the <i>RUNX1</i> gene with the outcome of the disease in acute myeloid leukemia (meta-analysis)
by: M. L. Nikonorova, et al.
Published: (2023-12-01) -
Family platelet disorder with propensity to acute myeloid leukemia: new family with RUNX1 mutation
by: V. O. Bobrynina, et al.
Published: (2014-07-01)